AzTrials
AzTrials

Coronary Artery DiseaseLEARNERSNCT06589323

Residents' Learning Curve of Intraoperative Transit-time Flowmetry and High-frequency Ultrasound in CABG (LEARNERS)

An observational study of Coronary Artery Disease, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Transit-time flowmetry (TTFM) allows grafts quality assessment during coronary artery bypass surgery by measuring the flow volume through them. Recently the intraoperative epicardial high-frequency ultrasound (HFUS) was introduced, with the possibility of capturing bidimensional images of the anastomoses. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Coronary Artery Disease
What is being tested?
Coronary artery bypass graft
Type of treatment
Surgery or procedure
How many people
80 participants
Where
1 siteItaly
Study dates
15 Sep 2024to 1 Apr 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.

Who may be able to join

  • Age >= 18 years old;
  • Written informed consent;
  • Indication to CABG surgery (both "on-pump" and "off-pump");
  • Stable angina, unstable angina or acute coronary syndrome without ST elevation (NSTEMI).

Who cannot join

  • Age >= 18 years old;
  • Written informed consent;
  • Indication to CABG surgery (both "on-pump" and "off-pump");
  • Stable angina, unstable angina or acute coronary syndrome without ST elevation (NSTEMI).

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Fondazione Policlinico Universitario "A. Gemelli" IRCCS

    Roma, RM, 00168

Other trials in Italy

About this study

Official title: Cardiac Surgery Residents' Learning Curve of Intraoperative Transit-time Flowmetry and High-frequency Ultrasound in Coronary Artery Bypass Surgery: the LEARNERS Study

Transit-time flowmetry (TTFM) allows grafts quality assessment during coronary artery bypass surgery by measuring the flow volume through them. Recently the intraoperative epicardial high-frequency ultrasound (HFUS) was introduced, with the possibility of capturing bidimensional images of the anastomoses. When combined, these two techniques provide high diagnostic yield reaching a positive predictive value of 100 percent.

Despite current guidelines recommend the employment of TTFM and HFUS, they remain largely underused probably because of limited information and the lack of standardization. Furthermore, surgeons must overcome a learning curve to handle both techniques properly, but few data are available according the current literature.

The main purpose of this study is to evaluate the complexity of HFUS and TTFM learning curve. This is a prospective, observational, monocentric cohort study. Adult patients undergoing coronary artery bypass surgery will be enrolled.

Read the detailed description

This is a prospective, observational, monocentric cohort study in which adult patients undergoing coronary artery bypass surgery will be enrolled.

Primary objective of this study is to evaluate the complexity of cardiac surgery residents' learning curve for grafts quality assessment with transit-time flowmetry (TTFM) and intraoperative epicardial high-frequency ultrasound (HFUS).

Secondary objectives are to evaluate the complexity of cardiac surgery residents' learning curve for grafts quality assessment with TTFM and HFUS as isolated techniques.

The study will last four months (three months for patients enrollment and data collection and one month for statistical analysis and scientific paper writing).

The trial will start after obtaining favourable opinion from the local Ethics Committee and could be considered completed when all the eight cardiac surgery residents involved have reached primary endpoint.

All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.

Patient data (anamnestic data, surgery description, intraoperative echographic and flowmetric measurements) will be recorded in a dedicated database. All data recorded in the database are commonly acquired for all patients undergoing this type of surgery and no further examinations will be performed for patients included in the trial.

The study will involve cardiac surgery residents with different levels of training and an expert cardiac surgeon who acts as supervisor and benchmark. Each resident will sign a dedicated informed consent form in the presence of a doctor foreign to the study protocol (Cardiac Surgery ward cardiologist). The residents will be "blinded" about the trial objective and the adopted score system. They will undergo a specific training including a quick lesson and a practical workshop to familiarize with the equipment.

During surgery, every graft will be evaluated through transit time flowmetry (TTFM) and intraoperative ultrasound control (HFUS).

In details, the ultrasound control is carried out through a dedicated sterile ultrasound probe connected to a machine (MiraQ - MEDISTIM) as soon as each anastomosis is completed. The result of the evaluation is recorded together with surgery data. This evaluation is intended to confirm the correct realization of the anastomosis and provides a proof of its patency.

Once each graft is completed, the resident will be given 60 seconds to acquire two HFUS recordings (short and long axis). After that, the supervisor will perform his personal recording which will stand as benchmark. The following items will be evaluated:

  1. Long axis recording acquired within 60 seconds [YES-> 1] [NO -> 0] B) Long axis recording judged as suitable by the supervisor [YES -> 1] [NO -> 0] C) Short axis recording acquired within 60 seconds [YES -> 1] [NO -> 0] D) Short axis recording judged as suitable by the supervisor [YES -> 1] [NO -> 0]
  2. Correct interpretation of the anastomosis as adequate or inadequate [YES -> no penalty] [NO -> total score becomes 0 and the resident isn't allowed to perform TTFM]

Each resident will be given a HFUS-related score from a minimum of 0 to a maximum of 4.

Whenever one of the recordings will be judged as non-suitable by the supervisor and consequently useless for a correct interpretation of the anastomosis (score 0 for items A and/or C), item E won't be evaluated and the HFUS will be given a total score of 0.

Next step will be the TFM evaluation, which is carried out through a specific sterile device connected to the same machine (MiraQ - MEDISTIM) once the patient has been weaned from the cardiopulmonary bypass and before protamine administration. This recording is performed under EKG and pressure-controlled conditions. Although there is no general agreement on the optimal mean arterial pressure at which the measurement has to be recorded, the investigators will adopt the standard used in the REQUEST study protocol (16), that is an average pressure of 80 mmHg.

The resident will acquire the TTFM recording after each graft is completed. To make the comparison as accurate as possible, the resident will perform TTFM evaluation on one graft at a time and successively the supervisor will do the same for each graft (making sure that delta between the pressure during the two recordings is lower than 10 percent and that no drug has been administered). The following items will be evaluated:

  1. Time necessary to acquire the measures [< 30 sec -> 1] [> 30 sec, < 60 -> 0.5] [> 60 sec -> 0] G) Need for multiple measurements before the final one: [>2 -> 0] [1 -> 0.5] [ 0 -> 1] H) Need to change probe dimensions: [NO -> 0] [YES-> 1]
  2. ACI [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] L) Mean Flow [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] M) Pulsatility Index [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] N) Backward Flow [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0] O) Diastolic Filling [delta between resident and supervisor measurements < 10%-> 1] [> 10%, < 20% -> 0.5] [> 20% -> 0]
  3. Correct interpretation of the graft quality as working [YES -> no penalty] [NO -> total score becomes 0]

Each resident will be given a TTFM-related score from a minimum of 0 to a maximum of 8.

The final score for each graft will be the sum of the two scores (HFUS and TTFM), from a minimum of 0 to a maximum of 12.

The same procedure will be repeated for each graft performed during the surgery.

Each resident will continue until reaching a ratio between total score and number of evaluated anastomoses of 11.

Our cardiac surgery unit performs between 5 and 10 coronary artery bypass grafts surgeries per week on average. Considering the inclusion and exclusion criteria and assuming that some patient may not give their informed consent, the investigators expect to enroll 4 patients per week. Considering that the involved residents (8 in total) will take part to the procedures in turn and that around 10 surgeries are needed to become autonomous, the investigators estimate to enroll 80 patients during a period of 3 months.

Data will be collected in a specific database (Microsoft Excel worksheet). The Kolgomorov-Smirnoff test was used to check for variables distribution. Continuous variables with a normal distribution are summarized by mean and standard deviation. Continuous variables with a non-normal distribution are expressed with median and interquartile range.

Categorical variables are reported as absolute frequency distribution and percentage. Continuous data are analyzed using the unpaired t-test or the Mann - Whitney test according to their distribution. Categorical data are compared with the Fisher's exact test. Statistical findings were considered significant if p value was less than 0.05. Statistical analysis will be performed with the statistic software SPSS (IBM).

Being tested
Coronary artery bypass graft
Medical subject headings
Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coronary artery bypass graftProcedure or surgery

    All patients included will undergo coronary artery bypass graft surgery. During surgery, every graft will be evaluated through transit time flowmetry (TTFM) and intraoperative ultrasound control (HFUS).

Study groups in NCT06589323
Study groupRoleWhat they receive
Group 1adult patients undergoing coronary artery bypass surgery
Receives: Procedure: Coronary artery bypass graft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of anastomoses needed to reach a ratio (total score/n. of anastomoses) >= 11

    Number of anastomoses needed to reach a ratio between total score and the number of studied anastomoses of 11 or more

    Measured: This evaluation will require from 1 to 3 months.

Secondary outcomes (2)
  1. Number of anastomoses needed to reach a ratio (HFUS score/n. of anastomoses) = 4

    Number of anastomoses needed to reach a ratio between the HFUS score and the number of studied anastomoses of 4

    Measured: This evaluation will require from 1 to 3 months.

  2. Number of anastomoses needed to reach a ratio (TTFM score/n. of anastomoses) >=7

    Number of anastomoses needed to reach a ratio between the TTFM score and the number of studied anastomoses of 7 or more

    Measured: This evaluation will require from 1 to 3 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start15 Sep 2024
  3. Primary completion1 Apr 2025
  4. Study completion1 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06589323
Sponsor's protocol ID
6735
Acronym
LEARNERS
Status last verified
Sep 2024
First submitted
27 Aug 2024
Last updated
2 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394. No abstract available.

    PubMed 30165437
  • Kieser TM, Rose S, Kowalewski R, Belenkie I. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts. Eur J Cardiothorac Surg. 2010 Aug;38(2):155-62. doi: 10.1016/j.ejcts.2010.01.026. Epub 2010 Feb 21.

    PubMed 20176493
  • Kieser TM, Taggart DP. The use of intraoperative graft assessment in guiding graft revision. Ann Cardiothorac Surg. 2018 Sep;7(5):652-662. doi: 10.21037/acs.2018.07.06.

    PubMed 30505750
  • Amin S, Pinho-Gomes AC, Taggart DP. Relationship of Intraoperative Transit Time Flowmetry Findings to Angiographic Graft Patency at Follow-Up. Ann Thorac Surg. 2016 May;101(5):1996-2006. doi: 10.1016/j.athoracsur.2015.10.101. Epub 2016 Feb 12.

    PubMed 26876343
  • Di Giammarco G, Pano M, Cirmeni S, Pelini P, Vitolla G, Di Mauro M. Predictive value of intraoperative transit-time flow measurement for short-term graft patency in coronary surgery. J Thorac Cardiovasc Surg. 2006 Sep;132(3):468-74. doi: 10.1016/j.jtcvs.2006.02.014.

    PubMed 16935097
  • Xenogiannis I, Zenati M, Bhatt DL, Rao SV, Rodes-Cabau J, Goldman S, Shunk KA, Mavromatis K, Banerjee S, Alaswad K, Nikolakopoulos I, Vemmou E, Karacsonyi J, Alexopoulos D, Burke MN, Bapat VN, Brilakis ES. Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies. Circulation. 2021 Aug 31;144(9):728-745. doi: 10.1161/CIRCULATIONAHA.120.052163. Epub 2021 Aug 30.

    PubMed 34460327
  • Di Giammarco G, Canosa C, Foschi M, Rabozzi R, Marinelli D, Masuyama S, Ibrahim BM, Ranalletta RA, Penco M, Di Mauro M. Intraoperative graft verification in coronary surgery: increased diagnostic accuracy adding high-resolution epicardial ultrasonography to transit-time flow measurement. Eur J Cardiothorac Surg. 2014 Mar;45(3):e41-5. doi: 10.1093/ejcts/ezt580. Epub 2013 Dec 12.

    PubMed 24335472
  • Gaudino M, Sandner S, Di Giammarco G, Di Franco A, Arai H, Asai T, Bakaeen F, Doenst T, Fremes SE, Glineur D, Kieser TM, Lawton JS, Lorusso R, Patel N, Puskas JD, Tatoulis J, Taggart DP, Vallely M, Ruel M. The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements. Circulation. 2021 Oct 5;144(14):1160-1171. doi: 10.1161/CIRCULATIONAHA.121.054311. Epub 2021 Oct 4.

    PubMed 34606302
  • Kieser TM. Graft quality verification in coronary artery bypass graft surgery: how, when and why? Curr Opin Cardiol. 2017 Nov;32(6):722-736. doi: 10.1097/HCO.0000000000000452.

    PubMed 28806185
  • Andreasen JJ, Nohr D, Jorgensen AS, Haahr PE. Peroperative epicardial ultrasonography of distal coronary artery bypass graft anastomoses using a stabilizing device. A feasibility study. J Cardiothorac Surg. 2020 Jan 8;15(1):3. doi: 10.1186/s13019-020-1057-x.

    PubMed 31915030
  • Andreasen JJ, Nohr D, Jorgensen AS. A case report on epicardial ultrasonography of coronary anastomoses using a stabilizing device without the use of ultrasound gel. J Cardiothorac Surg. 2019 Mar 13;14(1):59. doi: 10.1186/s13019-019-0882-2.

    PubMed 30866994
  • Wolf RK, Falk V. Intraoperative assessment of coronary artery bypass grafts. J Thorac Cardiovasc Surg. 2003 Sep;126(3):634-7. doi: 10.1016/s0022-5223(03)00747-5. No abstract available.

    PubMed 14502132
  • Budde RP, Meijer R, Dessing TC, Borst C, Grundeman PF. Detection of construction errors in ex vivo coronary artery anastomoses by 13-MHz epicardial ultrasonography. J Thorac Cardiovasc Surg. 2005 May;129(5):1078-83. doi: 10.1016/j.jtcvs.2004.09.002.

    PubMed 15867783
  • Jorgensen AS, Schmidt SE, Staalsen NH, Ostergaard LR. An Improved Algorithm for Coronary Bypass Anastomosis Segmentation in Epicardial Ultrasound Sequences. Ultrasound Med Biol. 2016 Dec;42(12):3010-3021. doi: 10.1016/j.ultrasmedbio.2016.07.014. Epub 2016 Sep 2.

    PubMed 27592558
  • Taggart DP, Thuijs DJFM, Di Giammarco G, Puskas JD, Wendt D, Trachiotis GD, Kieser TM, Kappetein AP, Head SJ. Intraoperative transit-time flow measurement and high-frequency ultrasound assessment in coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2020 Apr;159(4):1283-1292.e2. doi: 10.1016/j.jtcvs.2019.05.087. Epub 2019 Aug 22.

    PubMed 31685277

Questions about this trial

What is this clinical trial studying?

An observational study of Coronary Artery Disease, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of anastomoses needed to reach a ratio (total score/n. of anastomoses) >= 11 (time frame: This evaluation will require from 1 to 3 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06589323, which also lists 16 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in